Congenital Nasolacrimal Duct Obstruction

  • Saurabh Kamal
  • Mohammad Javed Ali
  • Vinod Gauba
  • Qasim Qasem


Congenital nasolacrimal duct obstruction (CNLDO) is a common cause of epiphora in children with incidence of symptoms ranging from 1.2 to 30 % [1, 2]. However the incidence of anatomic nasolacrimal duct obstruction seen in stillborn is much higher at around 73 %. It is believed that respiratory efforts, crying, and sucking create negative pressure within the nose which helps to break the membrane present at the nasolacrimal duct (NLD) opening. This spontaneous perforation usually occurs by 3–4 weeks of age, but if it fails, manifestations of CNLDO are seen [3]. Management of CNLDO is principally guided by natural history of the disease and high spontaneous remission rate by 1 year of age [2]. The standard of care now for non-resolving cases is endoscopic-assisted probing with or without intubation. There is an increasing role of dacryoendoscopy and simultaneous correction of associated intranasal abnormalities [4, 5].


Nasolacrimal Duct Orbital Cellulitis Nasolacrimal Duct Obstruction Treacher Collins Syndrome Balloon Catheter Dilation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Geurry D, Kendig EL. Congenital impatency on the naso-lacrimal duct. Arch Ophthalmol. 1948;39:193–204.CrossRefGoogle Scholar
  2. 2.
    Macewen CJ, Young JDH. Epiphora during the first year of life. Eye. 1991;5:596–600.PubMedCrossRefGoogle Scholar
  3. 3.
    Cassady JV. Developmental anatomy of nasolacrimal duct. Arch Ophthalmol. 1952;47:141–58.CrossRefGoogle Scholar
  4. 4.
    Wallace EJ, Cox A, White P, et al. Endoscopic-assisted probing for congenital nasolacrimal duct obstruction. Eye. 2006;20:998–1003.PubMedCrossRefGoogle Scholar
  5. 5.
    Lueder GT. Endoscopic treatment of intranasal abnormalities associated with nasolacrimal duct obstruction. J AAPOS. 2004;8:128–32.PubMedCrossRefGoogle Scholar
  6. 6.
    de la Cuadra-Blanco C, Peces-Pena MD, Janez-Escalada L, et al. Morphogenesis of the human excretory lacrimal system. J Anat. 2006;209:127–35.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Takahashi Y, Matsuda H, Nakamura Y, et al. Dacryoendoscopic findings of lacrimal passage with congenital punctal atresia. Orbit. 2013;32:338–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Jones LT, Wobig JL. Surgery of the eyelids and lacrimal system. Birmingham: Aesculapius; 1976. p. 162–4.Google Scholar
  9. 9.
    Kushner BJ. The management of nasolacrimal duct obstruction in children aged between 18 months and 4 years. J AAPOS. 1998;2:57–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Perry LJ, Jakobiec FA, Zakka FR, et al. Giant dacryocystomucopyocele in an adult: a review of lacrimal sac enlargements with clinical and histopathologic differential diagnoses. Surv Ophthalmol. 2012;57:474–85.PubMedCrossRefGoogle Scholar
  11. 11.
    Paysee EA, Coats DK, Bernstein JM, et al. Management and complications of congenital dacryocele with concurrent intranasal mucocele. J AAPOS. 2000;4:46–53.CrossRefGoogle Scholar
  12. 12.
    MacEwen CJ, Young JD, Barras CW, et al. Value of nasal endoscopy and probing in the diagnosis and management of children with congenital epiphora. Br J Ophthalmol. 2001;85:314–8.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Ali MJ, Psaltis AJ, Brunworth J, et al. Congenital dacryocele with large intranasal cysts. Efficacy of cruciate marsupialization, adjunctive procedures and outcomes. Ophthal Plast Reconstr Surg. 2014;30:346–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Francois J, Bacskulin J. External congenital fistulae of the lacrimal sac. Ophthalmologica. 1969;9:249–61.CrossRefGoogle Scholar
  15. 15.
    Welham RAN, Bergin DJ. Congenital lacrimal fistulas. Arch Ophthalmol. 1985;103:545–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Freitag SK, Woog JJ. Congenital nasolacrimal duct obstruction. Ophthalmol Clin North Am. 2000;13:705–18.CrossRefGoogle Scholar
  17. 17.
    Young JD, MacEwen CJ, Ogston SA. Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management. Eye. 1996;10:485–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Paediatric Eye Disease Investigator Group. Resolution of congenital nasolacrimal duct obstruction with nonsurgical management. Arch Ophthalmol. 2012;130:730–4.Google Scholar
  19. 19.
    Schnall BM. Paediatric nasolacrimal duct obstruction. Curr Opin Ophthalmol. 2013;24:421–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Paediatric Eye Disease Investigator Group. A randomized trial comparing the cost-effectiveness of two approaches for treating unilateral nasolacrimal duct obstruction. Arch Ophthalmol. 2012;130:1525–33.CrossRefGoogle Scholar
  21. 21.
    PEDIG. Primary treatment of nasolacrimal duct obstruction with probing in children less than four years. Ophthalmology. 2008;115:577–84.CrossRefGoogle Scholar
  22. 22.
    Honavar SG, Prakash VE, Rao GN. Outcome of probing for congenital nasolacrimal duct obstruction in older children. Am J Ophthalmol. 2000;130:42–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Maheshwari R. Success rate and causes of failure for late probing for congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 2008;45:168–71.PubMedCrossRefGoogle Scholar
  24. 24.
    Paediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children less than four years old. J AAPOS. 2008;12:451–5.CrossRefGoogle Scholar
  25. 25.
    Ali MJ, Naik MN, Honavar SG. Balloon dacryoplasty: ushering the new and routine era in minimally invasive lacrimal surgeries. Int Ophthalmol. 2013;33:203–10.PubMedCrossRefGoogle Scholar
  26. 26.
    Paediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children less than four years old. J AAPOS. 2008;12:445–50.CrossRefGoogle Scholar
  27. 27.
    Kashkouli MB, Beigi B, Parvaresh MM, et al. Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure? Br J Ophthalmol. 2003;87:1151–3.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Paediatric Eye Disease Investigator Group. Repeat probing for treatment of persistent nasolacrimal duct obstruction. J AAPOS. 2009;13:306–7.CrossRefGoogle Scholar
  29. 29.
    Repka MX, Chandler DL, Holmes JM, Paediatric Eye Disease Investigator Group, et al. Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing. Arch Ophthalmol. 2009;127:633–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Sasaki T, Nagata Y, Sugiyama K. Nasolacrimal duct obstruction classified by dacryoendoscopy and treated with inferior meatal dacryorhinotomy: part II. Inferior meatal dacryorhinotomy. Am J Ophthalmol. 2005;140:1070–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Emmerich KH, Steinhauer J, Meyer-Rüsenberg HW, et al. Dacryoendoscopy – current status. Ophthalmologe. 1998;95:820–2.PubMedCrossRefGoogle Scholar
  32. 32.
    Leibovitch I, Selva D, Tsirbas A, et al. Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction. Graefes Arch Clin Exp Ophthalmol. 2006;244:1250–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  • Saurabh Kamal
    • 1
  • Mohammad Javed Ali
    • 2
  • Vinod Gauba
    • 3
  • Qasim Qasem
    • 4
  1. 1.Ophthalmic Plastics SurgeryL.V. Prasad Eye InstituteHyderabadIndia
  2. 2.Dacryology ServiceL.V. Prasad Eye InstituteBanjara Hills, HyderabadIndia
  3. 3.Ophthalmic Plastics SurgeryImperial Healthcare InstituteDubaiUAE
  4. 4.Pediatric OphthalmologyImperial Healthcare InstituteDubaiUAE

Personalised recommendations